Lv5
1034 积分 2021-03-19 加入
Ankylosing spondylitis: An overview of pathophysiology and therapeutic landscape
5天前
已完结
The relationship between interleukin and ankylosing spondylitis
5天前
已关闭
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
6天前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
17天前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
17天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
19天前
已完结
Discovery of novel dual Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis
30天前
已完结
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity
2个月前
已完结
Defining IL‐6 levels in healthy individuals: A meta‐analysis
2个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
3个月前
已完结
皖公网安备34019202002308
